Page last updated: 2024-08-25

nagilactone c and Alveolitis, Fibrosing

nagilactone c has been researched along with Alveolitis, Fibrosing in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, X; Feng, ZL; Li, A; Lin, LG; Liu, LJ; Lu, JJ; Xiao, X; Zhang, LL1

Other Studies

1 other study(ies) available for nagilactone c and Alveolitis, Fibrosing

ArticleYear
Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
    Toxicology and applied pharmacology, 2020, 01-15, Volume: 389

    Topics: Animals; Biomarkers; Bleomycin; Cells, Cultured; Diterpenes; Female; Fibroblasts; Humans; Lung; Mice; Mice, Inbred C57BL; Myofibroblasts; Pulmonary Fibrosis; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Smad2 Protein; Terpenes; Transforming Growth Factor beta1

2020